Back

Added value of genetics on top of clinics in predicting treatability of dilated cardiomyopathy patients

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Myocardial Disease – Clinical Dilated Cardiomyopathy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Associate Professor Job Verdonschot

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

17 More presentations in this session

Presentation thumbnail
Miss I. Mueller (Berlin, DE)
Abstract Slides
Presentation thumbnail
Doctor D. Mlejnek (Brno, CZ)
Abstract
Presentation thumbnail
Professor O. Blagova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor R. Adam (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Mrs Y. Frolova (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Myocardial Disease – Clinical

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Do the variables that the clinical cardiologist looks at when requesting a genetic study in the study of idiopathic dilated cardiomyopathy have predictive value?
29 June 2021
thumbnail
Congress Session
It’s all about genetics
17 May 2025
thumbnail
Congress Presentation
Genotype guided therapy
12 May 2026
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources